TriSalus Life Sciences (TLSI) Return on Capital Employed Growth (3y) (2024 - 2026)
TriSalus Life Sciences (TLSI) Return on Capital Employed Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 1,318.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -247.00 |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | - |
| 10 | TriSalus Life Sciences | 222.70 Mn | 166.14 Mn | 7.67 Mn | 11,481.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,481.00 |
| Dec 31, 2025 | -9,046.00 |
| Sep 30, 2025 | -10,760.00 |
| Jun 30, 2025 | -11,963.00 |
| Mar 31, 2025 | -21,741.00 |
| Dec 31, 2024 | -23,216.00 |